TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2011-11-10

Name: TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2011-11-10
Creator: TuHURA BIOSCIENCES, INC./NV

What TuHURA BIOSCIENCES, INC./NV reported in its quarterly report filed 2011-11-10 (fiscal Q1 2012): 12 published measures, 26 facts as tagged in accession 0001127855-11-000562.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-11-10
Fiscal period: fiscal Q1 2012
Accession: 0001127855-11-000562 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TuHURA BIOSCIENCES, INC./NV filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-09-30	6,837	USD
At 2011-06-30	10,695	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-09-30	6,837	USD
At 2011-06-30	10,695	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-09-30	6,837	USD
At 2011-06-30	5,695	USD
At 2010-09-30	35,998	USD
At 2010-06-30	44,561	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-3,858	USD	92
2009-06-24 to 2011-09-30	-42,576	USD	829
2010-07-01 to 2010-09-30	-7,910	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	1,142	USD	92
2009-06-24 to 2011-09-30	-42,576	USD	829
2010-07-01 to 2010-09-30	-8,563	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2009-06-24 to 2011-09-30	49,500	USD	829

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-09-30	-42,576	USD
At 2011-06-30	-38,718	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	5,950,000	shares	92
2010-07-01 to 2010-09-30	5,950,000	shares	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-3,858	USD	92
2009-06-24 to 2011-09-30	-42,576	USD	829
2010-07-01 to 2010-09-30	-7,910	USD	92

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-09-30	43,550	USD
At 2011-06-30	43,550	USD

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	5,000	USD	92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2010-07-01 to 2010-09-30	-653	USD	92

Inspect the source

Entity: TuHURA BIOSCIENCES, INC./NV / CIK 0001498382
Captured: 2026-09-20T09:11:11.339Z
SEC response SHA-256: cbfb2cda3307f7af300be1fc56e9d85ca5186f16e46a189d675574c95ee74f5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001498382.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))